Laman UtamaCONCORDBIO • NSE
add
Concord Biotech Ltd
Tutup sebelumnya
₹1,798.60
Julat hari
₹1,790.00 - ₹1,838.30
Julat tahun
₹1,345.00 - ₹2,664.00
Permodalan pasaran
191.03B INR
Bilangan Purata
263.63K
Nisbah P/E
51.41
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 4.30B | 34.77% |
Perbelanjaan pengendalian | 962.43J | 13.00% |
Pendapatan bersih | 1.40B | 47.75% |
Margin untung bersih | 32.66 | 9.63% |
Pendapatan bagi setiap syer | 13.42 | 47.80% |
EBITDA | 1.89B | 33.07% |
Kadar cukai berkesan | 23.51% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.18B | 12.80% |
Jumlah aset | 20.34B | 19.61% |
Jumlah liabiliti | 2.22B | 27.27% |
Jumlah ekuiti | 18.13B | — |
Syer tertunggak | 104.61J | — |
Harga kepada buku | 10.38 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 25.78% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.40B | 47.75% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Diasaskan
2000
Tapak web
Pekerja
1,377
